Showing items tagged as life sciences

  • jon-b-blog_01_358x160

    Rapid Acceleration in Technology for Life Sciences Quality and Manufacturing

    We have built technology for life sciences quality and manufacturing for more than 25 years and I have been involved in that effort for 19 years. It wasn’t until 2014 that we realized the why behind what we do and it wasn’t until 2020 that our mission became crystal clear to everyone on our teams.

    Full story
  • 2020-bl-coda-corp-vaccines_132x132

    The Fundamentals of Immunization, Part 2

    The race to develop a safe and effective vaccine against COVID-19 is on, and it has everyone talking. This is the second of a three-part series on the fundamentals of immunization.

    Full story
  • 2020-bl-thumb-align-quality-across-ecosystem_132x132

    How to Align Quality Across an Expanding Ecosystem

    As companies grow more reliant on geographically dispersed contractors, partners, vendors and business units, it gets harder to align quality across all the entities involved. Learn how global companies like Fagron maintain quality consistency across multiple sites and discover why connecting data and processes within a robust digital platform is the surest way to align quality across your entire ecosystem.

    Full story
  • 2020-bl-thumb-3-advantages-data-centric-quality-mindset

    3 Advantages of a Data-Centric Quality Mindset

    A seismic shift is coming to life sciences manufacturing, and that’s the move from documents to data. With a data-centric mindset, it’s possible to glean valuable insights while gaining a tremendous competitive advantage.

    Full story
  • 2020-bl-thumb-masters-conference-covid-thank-you

    A Heartfelt Thank-You to Our Customers

    In response to COVID-19, our customers and so many others are working hard on the front lines, behind the scenes, and everywhere in between. From everyone at MasterControl: Thank you!

    Full story
  • 2020-bl-thumb-covid-19-and-fdas-response

    Weighing FDA's Response to the COVID-19 Pandemic

    The rapid global spread of the coronavirus caught many world governments and health authorities off guard. Gina Guido-Redden, co-founder and COO of Coda Corp USA, offers a comprehensive review of the how the U.S. Food and Drug Administration (FDA) has responded thus far to the pandemic under 21 CFR.

    Full story
  • 2020-bl-thumb-working-together-to-beat-covid-19

    Working Together to Beat COVID-19

    At this point, COVID-19 has touched everyone’s life in some way. While we’re still struggling to keep up with the pandemic, many of our customers are undergoing initiatives to test and/or treat the virus.

    Full story
  • 2020-bl-thumb-coronavirus-global-supply-chain-risk

    How Coronavirus, Brexit and Hurricanes Are Impacting the Global Supply Chain

    Coronavirus is the newest in a string of natural and man-made disasters and events disrupting the global supply chain. Governments and the private sector need to take a collaborative risk-management approach to planning measures to confront pandemics and other events that threaten the stability of global supply chains and our ability to meet ensuing demand.

    Full story
  • 2020-bl-thumb-gartner-reprint-supply-chain-pharma-medtech

    How Healthy Is Your Supply Chain?

    Life sciences supply chains are unique. Pharmaceutical and medical device are even more so. Finding out industry standards and how your supply chain can improve are important questions that should be answered by the experts. Gartner recently produced “Supply Chain Benchmarking Data Reveals Differences Between Pharmaceutical and Medical Device Manufacturers” to provide those insights.

    Full story
  • 2020-bl-thumb-coda-corp-fda-and-data-integrity

    In a Data-Driven Ecosystem, Don't Let Data Integrity Be Your Achilles' Heel

    Data has massive potential to revolutionize the life sciences for patients, regulators and for manufacturers. Yet at the same time, data integrity remains one of regulatory bodies’ biggest concerns. Learn what you can do to improve your company’s data integrity for regulatory inspections.

    Full story
  • 2020-bl-thumb-7-steps-to-capa-success

    7 Steps to Ensure CAPA Success

    Inadequate quality management and poor data can be costly for a life sciences company or similarly regulated industry. However, a strong corrective action preventative action (CAPA) program paired with a digital CAPA management tool can help differentiate your company from the competition.

    Full story
  • 2019-nl-bl-thumb-assessment-elevens

    An Assessment of the ‘Elevens’: EU’s Annex 11 and FDA 21 CFR Part 11

    The European Union’s Annex 11 and the U.S. Food and Drug Administration’s (FDA) 21 CFR Part 11 good manufacturing practice (GMP) guidances cover much of the same regulatory ground but also have differences. Find out how both regulatory documents affect life sciences manufacturers.

    Full story
  • 2019-bl-thumb-summit-irene-brodsky

    Art Intersects With Inspiring Science Applications at the 2019 Masters Summit

    Science and art may seem to have few commonalities, but creative achievements like origami models and musical compositions are closely linked with beneficial scientific applications, according to the keynote addresses at the 2019 Masters Summit. Learn about the insights that origami innovator Dr. Robert Lang and independent filmmaker Irene Taylor Brodsky have discovered in the space where art and technology intersect.

    Full story
  • 2019-bl-thumb-how-the-tga-regulates-drugs-and-devices

    Tips on How the TGA Regulates Drugs, Devices and Combination Products

    Global regulatory requirements are seemingly in a state of constant flux. Thus, it can be confusing for life sciences companies to grasp the exact nature of each region’s regulatory agency policies. This article breaks down some of the regulatory basics and more nuanced portions of Australia’s Therapeutic Goods Administration (TGA).

    Full story
  • 2019-bl-thumb-dia-takeaways

    DIA Global 2019 Recap: 3 Themes Shaping the Future of Life Sciences

    Patient centricity, transformative technologies and the importance of high-quality and clinically meaningful data were the major themes at DIA Global 2019. Learn about the trends having the biggest impact on the evolving life sciences landscape.

    Full story
  • 132x132

    Coming Soon: The New Look of MasterControl

    A lot has changed since MasterControl’s beginning in 1993. As technology transforms the way we do business and quality becomes a true competitive advantage, MasterControl is evolving to better support the companies and industries we serve. We’re excited to announce that MasterControl will unveil a new look on May 1.

    Full story
  • 2019-bl-thumb-big-data-concepts

    Big Data Trends Urge Life Sciences Executives to Modernize Key Business Functions

    A new phase of the Industrial Revolution is ushering in new technologies and modernized operational strategies that no life sciences industry executive can afford to ignore. Regulated companies are highly encouraged to plan for future relevance and success by modernizing key processes and operations.

    Full story
  • 2019-bl-thumb-the-war-on-paper

    R.I.P. Paper Processes

    For many clinical, quality and manufacturing professionals, a change in process or technologies can be hard. But now, more than ever in life sciences, there is a need to digitize and move off paper-based or hybrid solutions. Through small automation pilots, the pains of transformation get eased while opening up opportunities that unlock a wealth of data-driven insights.

    Full story
  • 2018-bl-thumb-pwc-logo

    PwC Report Analyzes Health Care Policy Issues

    PwC’s Health Research Institute recently issued a report on the U.S. midterm election that analyzes policy issues that may well impact the American health care industry for years to come, particularly those in the pharmaceutical and life science industries. Learn what this means for manufacturers.

    Full story
  • 2018-bl-thumb-raps-logo

    Advancing the Regulatory Profession in Utah

    Based on recent economic study and the establishment of the Silicon Slopes technology corridor, Utah has one of the fastest-growing life sciences communities in the U.S. Learn about the Regulatory Affairs Professionals Society’s (RAPS) new Utah Chapter and what the organization is doing to attract more regulatory affairs experts to life sciences careers.

    Full story
[ { "key": "fid#1", "value": ["GxP Lifeline Blog"] } ]